Open AccessA retrospective cohort study of polatuzumab vedotin combined with immunochemotherapy in Chinese patients with relapse/refractory diffuse large B cell lymphoma
Author(s) -
Yanyan Liu,
Zhijun Wuxiao,
Fancong Kong,
Jifeng Feng,
Jianqiu Wu,
Zhihua Yao,
Weilun Zhou,
Fei Li
Publication year - 2022
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm-22-4593
Subject(s) - medicine , neutropenia , regimen , rituximab , tolerability , diffuse large b cell lymphoma , adverse effect , transplantation , refractory (planetary science) , population , oncology , surgery , gastroenterology , lymphoma , chemotherapy , physics , astrobiology , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom